Temazepam
Short-acting 3-hydroxy benzodiazepine. Clinical hypnotic (Restoril) AND minor active metabolite of diazepam (CYP3A4-mediated). t½ ~10 h.
Projected serum levels — 15 mg, once daily
Maintenance schedule: 15 mg once daily (oral).
Modeled steady state after ~1 days: peak ≈ 11.0 mg, trough ≈ 0.19 mg body load. Population-based estimate over 15 days for a 15 mg dose at a 70 kg reference body mass — the interactive app scales curves to your doses, timing, and body mass.
Key facts
- Category
- Benzodiazepine
- Route modeled
- Oral
- Model confidence
- inferred
- Half-life
- 10 h
- Common dose
- 15 mg
- Suggested maximum
- 30 mg/day
- Reference dose range
- 7.5–30 mg (single dose)
- Suggested cadence
- once daily
- Validated against
- 30 mg oral — Cmax 0.90 mg/L at 1.2 h
Documented interactions
-
watch
GABA (Gamma-Aminobutyric Acid) + Temazepam
GABA (Gamma-Aminobutyric Acid) and Temazepam both push the gaba a in the same direction.
-
watch
Ivermectin (Stromectol) + Temazepam
Ivermectin (Stromectol) and Temazepam both push the gaba a in the same direction.
-
watch
L-Theanine + Temazepam
L-Theanine and Temazepam both push the gaba a in the same direction.
-
watch
Taurine + Temazepam
Taurine and Temazepam both push the gaba a in the same direction.
Serum checks 4 modeled interaction pairings for temazepam across your whole stack — absorption conflicts, enzyme inhibition, and nutrient depletion included.